APC 366 tryptase inhibitor: Began Phase Ib trial in 30 patients of multiple doses of up to 5 mg three times daily, over four days. The drug will be given by inh

Arris Pharmaceutical Corp. (ARRS), South San Francisco Product: APC 366 tryptase inhibitor Indication: Mild asthma and other causes of hyperresponsive airways Status: Began Phase Ib trial in 30 pati...